The growth of resistant forms of tuberculosis is a global health crisis. IGH is partnering with Johns Hopkins University and Hinduja Hospital in Mumbai to undertake a study of treatment outcomes. The study includes detailed data on clinical and functional outcomes of patients, as well as costs, including patient and caregiver time. Drs Zarir Udwadia and Amita Gupta lead the study. An important goal of this study is to demonstrate the feasibility of measuring outcomes of new drugs in treating diseases in the presence of complex and individual-specific treatment protocols. The study is designed to test the practical effectiveness of new drugs as they are introduced to the highly active tuberculosis clinic at Hinduja Hospital. It thus provides, on a small scale, an example of the kind of study that can support measurement by the Health Impact Fund to aid in the assessment of the health impact of new drugs registered with the fund.
Dr. Zarir Udwadia is a consultant chest physician at the Hinduja Hospital, Breach Candy Hospital, and Parsee General Hospital. He is an MD, DNB, FRCP (London), and FCCP (USA). A post-graduate of the Grant Medical College, Bombay, he has spent five years training in various centers of excellence in the UK, including the prestigious Brompton Hospital in London. On his return to India he established an active chest department at Hinduja hospital. This includes Bombay’s busiest bronchoscopy and PFT services and the city’s first sleep laboratory.
Dr. Amita Gupta, Deputy Director of the Johns Hopkins University (JHU) Center for Clinical Global Health Education (CCGHE), is an Associate Professor of Medicine in the Division of Infectious Diseases (primary appointment) and Associate Professor of International Health (joint appointment) at JHU. Born to Indian parents, she grew up in the United States, England, and France. She completed her undergraduate education in internal medicine at San Francisco General Hospital-University of San Francisco. She then became an Epidemic Intelligence Service Officer focusing on global foodborne and diarrheal diseases epidemiology in the US Centers for Disease Control and Prevention. After which she came to JHU and completed an infectious diseases fellowship and a Masters in Health Sciences.
For more information about this study, contact Rachel Payne at email@example.com
Photo courtesy of Day Donaldson.